These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10563597)

  • 1. Vision for the future.
    Beran R; Pachlatko C
    Epilepsia; 1999; 40 Suppl 8():55-6. PubMed ID: 10563597
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacoeconomics of the new antiepileptic drugs.
    Heaney D
    Epilepsia; 1999; 40 Suppl 8():25-31. PubMed ID: 10563592
    [No Abstract]   [Full Text] [Related]  

  • 3. World-wide disparities in epilepsy care: a Latin American outlook.
    Fandiño-Franky J; Silfvenius H
    Epilepsia; 1999; 40 Suppl 8():48-54. PubMed ID: 10563596
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic analysis of epilepsy care.
    Beran RG
    Epilepsia; 1999; 40 Suppl 8():19-24. PubMed ID: 10563591
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of surgical and medical costs for refractory epilepsy.
    Platt M; Sperling MR
    Epilepsia; 2002; 43 Suppl 4():25-31. PubMed ID: 12059998
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimating the costs of epilepsy: an international comparison of epilepsy cost studies.
    Kotsopoulos IA; Evers SM; Ament AJ; de Krom MC
    Epilepsia; 2001 May; 42(5):634-40. PubMed ID: 11380571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of epilepsy care to the community.
    Pachlatko C
    Seizure; 1997 Dec; 6(6):415-7. PubMed ID: 9530935
    [No Abstract]   [Full Text] [Related]  

  • 8. [The costs of epilepsy in Germany].
    Dodel R; Rosenow F; Hamer HM
    Pharm Unserer Zeit; 2007; 36(4):298-305. PubMed ID: 17623320
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary care treatment of epilepsy with phenobarbital in rural China: cost-outcome analysis from the WHO/ILAE/IBE global campaign against epilepsy demonstration project.
    Ding D; Hong Z; Chen GS; Dai XY; Wu JZ; Wang WZ; De Boer HM; Sander JW; Prilipko L; Chisholm D
    Epilepsia; 2008 Mar; 49(3):535-9. PubMed ID: 18302628
    [No Abstract]   [Full Text] [Related]  

  • 10. The costs of epilepsy and cost-based evaluations of anticonvulsants.
    Johnson WG
    Pharmacoeconomics; 1997 Oct; 12(4):446-59. PubMed ID: 10174311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epilepsy in adults: a costs-of-illness study].
    Vlasov PK; Orekhova NV; Filatova NV; Leonova MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):44-7. PubMed ID: 20873473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of antiepileptic drug therapy: a methodologic review.
    Levy P
    Epilepsia; 2002 May; 43(5):550-8. PubMed ID: 12027918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of epilepsy in India.
    Thomas SV; Sarma PS; Alexander M; Pandit L; Shekhar L; Trivedi C; Vengamma B
    Epilepsia; 2001 Aug; 42(8):1052-60. PubMed ID: 11554893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some medical-social aspects of the therapy of epilepsy with drugs of new generation: financial side].
    Gromov SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(8):59-61. PubMed ID: 11552639
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy.
    Heaney DC; Sander JW
    Neurology; 1999 Aug; 53(3):657-8. PubMed ID: 10449148
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost minimization analysis of antiepileptic drugs in newly diagnosed epilepsy in 12 European countries.
    Heaney DC; Shorvon SD; Sander JW; Boon P; Komarek V; Marusic P; Dravet C; Perucca E; Majkowski J; Lima JL; Arroyo S; Tomson T; Ried S; van Donselaar C; Eskazan E; Peeters P; Carita P; Tjong-a-Hung I; Myon E; Taieb C
    Epilepsia; 2000; 41 Suppl 5():S37-44. PubMed ID: 11045437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study.
    Nsengiyumva G; Druet-Cabanac M; Nzisabira L; Preux PM; Vergnenègre A
    Epilepsia; 2004 Jun; 45(6):673-7. PubMed ID: 15144433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
    Hamer HM; Spottke A; Aletsee C; Knake S; Reis J; Strzelczyk A; Oertel WH; Rosenow F; Dodel R
    Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy.
    Markowitz MA; Mauskopf JA; Halpern MT
    Neurology; 1998 Oct; 51(4):1026-33. PubMed ID: 9781524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data.
    Begley CE; Famulari M; Annegers JF; Lairson DR; Reynolds TF; Coan S; Dubinsky S; Newmark ME; Leibson C; So EL; Rocca WA
    Epilepsia; 2000 Mar; 41(3):342-51. PubMed ID: 10714408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.